Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region

Wayne H H Sheu, Li Nong Ji, Wannee Nitiyanant, Sei-Hyun Baik, Donald Yin, Panagiotis Mavros, Siew Pheng Chan

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Aims: We examined the relationship of hypoglycemic symptoms with health-related quality of life and worry about hypoglycemia among type 2 diabetic patients using oral antihyperglycemic agents (AHA) in the Asia-Pacific region. Methods: A total of 2257 type 2 diabetic patients with at least 6 months of oral AHA were enrolled in China, Korea, Malaysia, Thailand, and Taiwan. Quality of life was measured with the EuroQol Visual Analog Scale (EQ-VAS) and EuroQol-5 Dimensions questionnaire (EQ-5D), and worry about hypoglycemia with the worry subscale of the Hypoglycemic Fear Survey-II (HFS). Results: The mean (SD) age was 58.7 (10.2) years and HbA 1c was 7.5% (1.5). The proportion of patients with an HbA 1c <6.5% and <7% was 24.9% and 41.8%, respectively. Hypoglycemic symptoms in the prior 6 months were reported by 35.8% of patients. Mean scores on the EQ-VAS and the EQ-5D were significantly lower for patients who had hypoglycemic symptoms compared to those who did not (73.6 vs. 76.9, p<0.001; 0.88 vs. 0.90, p<0.0001, respectively), whereas mean score on the HFS was significantly higher (12.5 vs. 6.3, p<0.001). In multivariate models, hypoglycemic symptoms were independently associated with scores on the EQ-5D, EQ-VAS, and HFS (all p≤0.01-0.001). Symptom severity was positively associated with fear of hypoglycemia (all p≤0.001). Conclusion: Hypoglycemic symptoms were associated with reduced quality of life and increased patient worry in patients with type 2 diabetes treated with AHA.

Original languageEnglish
Pages (from-to)141-148
Number of pages8
JournalDiabetes Research and Clinical Practice
Volume96
Issue number2
DOIs
Publication statusPublished - 2012 May 1

Fingerprint

Hypoglycemia
Hypoglycemic Agents
Type 2 Diabetes Mellitus
Quality of Life
Fear
Visual Analog Scale
Malaysia
Thailand
Korea
Taiwan
Surveys and Questionnaires
China

Keywords

  • Diabetes
  • Hypoglycemia
  • Quality of life
  • Worry

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region. / Sheu, Wayne H H; Ji, Li Nong; Nitiyanant, Wannee; Baik, Sei-Hyun; Yin, Donald; Mavros, Panagiotis; Chan, Siew Pheng.

In: Diabetes Research and Clinical Practice, Vol. 96, No. 2, 01.05.2012, p. 141-148.

Research output: Contribution to journalArticle

@article{23b6b17ed8ab4c8c8e933c4afb664b58,
title = "Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region",
abstract = "Aims: We examined the relationship of hypoglycemic symptoms with health-related quality of life and worry about hypoglycemia among type 2 diabetic patients using oral antihyperglycemic agents (AHA) in the Asia-Pacific region. Methods: A total of 2257 type 2 diabetic patients with at least 6 months of oral AHA were enrolled in China, Korea, Malaysia, Thailand, and Taiwan. Quality of life was measured with the EuroQol Visual Analog Scale (EQ-VAS) and EuroQol-5 Dimensions questionnaire (EQ-5D), and worry about hypoglycemia with the worry subscale of the Hypoglycemic Fear Survey-II (HFS). Results: The mean (SD) age was 58.7 (10.2) years and HbA 1c was 7.5{\%} (1.5). The proportion of patients with an HbA 1c <6.5{\%} and <7{\%} was 24.9{\%} and 41.8{\%}, respectively. Hypoglycemic symptoms in the prior 6 months were reported by 35.8{\%} of patients. Mean scores on the EQ-VAS and the EQ-5D were significantly lower for patients who had hypoglycemic symptoms compared to those who did not (73.6 vs. 76.9, p<0.001; 0.88 vs. 0.90, p<0.0001, respectively), whereas mean score on the HFS was significantly higher (12.5 vs. 6.3, p<0.001). In multivariate models, hypoglycemic symptoms were independently associated with scores on the EQ-5D, EQ-VAS, and HFS (all p≤0.01-0.001). Symptom severity was positively associated with fear of hypoglycemia (all p≤0.001). Conclusion: Hypoglycemic symptoms were associated with reduced quality of life and increased patient worry in patients with type 2 diabetes treated with AHA.",
keywords = "Diabetes, Hypoglycemia, Quality of life, Worry",
author = "Sheu, {Wayne H H} and Ji, {Li Nong} and Wannee Nitiyanant and Sei-Hyun Baik and Donald Yin and Panagiotis Mavros and Chan, {Siew Pheng}",
year = "2012",
month = "5",
day = "1",
doi = "10.1016/j.diabres.2011.12.027",
language = "English",
volume = "96",
pages = "141--148",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region

AU - Sheu, Wayne H H

AU - Ji, Li Nong

AU - Nitiyanant, Wannee

AU - Baik, Sei-Hyun

AU - Yin, Donald

AU - Mavros, Panagiotis

AU - Chan, Siew Pheng

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Aims: We examined the relationship of hypoglycemic symptoms with health-related quality of life and worry about hypoglycemia among type 2 diabetic patients using oral antihyperglycemic agents (AHA) in the Asia-Pacific region. Methods: A total of 2257 type 2 diabetic patients with at least 6 months of oral AHA were enrolled in China, Korea, Malaysia, Thailand, and Taiwan. Quality of life was measured with the EuroQol Visual Analog Scale (EQ-VAS) and EuroQol-5 Dimensions questionnaire (EQ-5D), and worry about hypoglycemia with the worry subscale of the Hypoglycemic Fear Survey-II (HFS). Results: The mean (SD) age was 58.7 (10.2) years and HbA 1c was 7.5% (1.5). The proportion of patients with an HbA 1c <6.5% and <7% was 24.9% and 41.8%, respectively. Hypoglycemic symptoms in the prior 6 months were reported by 35.8% of patients. Mean scores on the EQ-VAS and the EQ-5D were significantly lower for patients who had hypoglycemic symptoms compared to those who did not (73.6 vs. 76.9, p<0.001; 0.88 vs. 0.90, p<0.0001, respectively), whereas mean score on the HFS was significantly higher (12.5 vs. 6.3, p<0.001). In multivariate models, hypoglycemic symptoms were independently associated with scores on the EQ-5D, EQ-VAS, and HFS (all p≤0.01-0.001). Symptom severity was positively associated with fear of hypoglycemia (all p≤0.001). Conclusion: Hypoglycemic symptoms were associated with reduced quality of life and increased patient worry in patients with type 2 diabetes treated with AHA.

AB - Aims: We examined the relationship of hypoglycemic symptoms with health-related quality of life and worry about hypoglycemia among type 2 diabetic patients using oral antihyperglycemic agents (AHA) in the Asia-Pacific region. Methods: A total of 2257 type 2 diabetic patients with at least 6 months of oral AHA were enrolled in China, Korea, Malaysia, Thailand, and Taiwan. Quality of life was measured with the EuroQol Visual Analog Scale (EQ-VAS) and EuroQol-5 Dimensions questionnaire (EQ-5D), and worry about hypoglycemia with the worry subscale of the Hypoglycemic Fear Survey-II (HFS). Results: The mean (SD) age was 58.7 (10.2) years and HbA 1c was 7.5% (1.5). The proportion of patients with an HbA 1c <6.5% and <7% was 24.9% and 41.8%, respectively. Hypoglycemic symptoms in the prior 6 months were reported by 35.8% of patients. Mean scores on the EQ-VAS and the EQ-5D were significantly lower for patients who had hypoglycemic symptoms compared to those who did not (73.6 vs. 76.9, p<0.001; 0.88 vs. 0.90, p<0.0001, respectively), whereas mean score on the HFS was significantly higher (12.5 vs. 6.3, p<0.001). In multivariate models, hypoglycemic symptoms were independently associated with scores on the EQ-5D, EQ-VAS, and HFS (all p≤0.01-0.001). Symptom severity was positively associated with fear of hypoglycemia (all p≤0.001). Conclusion: Hypoglycemic symptoms were associated with reduced quality of life and increased patient worry in patients with type 2 diabetes treated with AHA.

KW - Diabetes

KW - Hypoglycemia

KW - Quality of life

KW - Worry

UR - http://www.scopus.com/inward/record.url?scp=84860518968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860518968&partnerID=8YFLogxK

U2 - 10.1016/j.diabres.2011.12.027

DO - 10.1016/j.diabres.2011.12.027

M3 - Article

C2 - 22265956

AN - SCOPUS:84860518968

VL - 96

SP - 141

EP - 148

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 2

ER -